脂质体内多克索鲁比的高分子处理阻碍了其在细胞中的治疗效果
Annalisa Carretta1, Aldo Moscardini1, Giovanni Signore2,3
1Scuola Normale Superiore, Laboratorio NEST, Piazza San Silvestro 12, 56127 Pisa, Italy.
Molecular therapy. Oncology
|July 25, 2024
概括
脂质体封装的多克索鲁比 (L-DOX) 在进入细胞时释放结晶的纳米棒,导致药物迅速流出,与自由多克索鲁比相比,抗癌疗效降低.
科学领域:
- 纳米医学是一种纳米医学.
- 癌症治疗 癌症治疗
- 细胞生物学 细胞生物学
背景情况:
- 脂质体封装多克索鲁比 (L-DOX) 显示临床成功,但在体外有效性降低.
- 之前的研究缺乏对这种差异的机制解释.
研究的目的:
- 研究L-DOX的细胞内处理和细胞吸收.
- 阐明L-DOX与自由多克索鲁比辛相比功效降低的机制.
主要方法:
- 利用多克索鲁比的内在光和时间解析光学显微镜.
- 在各种体外细胞模型中分析了L-DOX吸收和细胞内处理.
主要成果:
- 在细胞进入时,L-DOX在细胞质中迅速释放结晶的多克索鲁比辛纳米棒.
- 这些纳米棒分解成纤维状衍生物,促进药物单体的释放和排放.
- 建立了稳定状态,限制了细胞内药物保留和疗效.
结论:
- 与免费药物相比,脂质细胞介导的药物传递在细胞内保留药物的效率较低.
- 这些发现解释了对L-DOX的相矛盾的体外和临床数据.
- 这些结果需要重新评估封装抗癌药物的合成设计.
相关概念视频
Factors Affecting Dissolution: Particle Size and Effective Surface Area
781
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
781
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
191
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
191


